IDEX Health & Science LLC designs, develops, and manufactures liquid subassemblies and precision components for a wide range of applications requiring precise control and measurement.
Company Description
IDEX Health & Science LLC designs, develops, and manufactures liquid subassemblies and precision components for a wide range of applications requiring precise control and measurement. We specialize in component integration that results in innovative and optimized OEM fluidic systems. IDEX Health & Science is the synthesis of leading component and technology suppliers to the analytical instrumentation, in vitro diagnostics, biotechnology, and laboratory markets. Our brands include Eastern Plastics, Innovadyne, Ismatec, Isolation Technologies, Rheodyne, Sapphire Engineering, Systec, and Upchurch Scientific.
Chief Chromatographic Techniques Supported
Markets Served
Major Products/Services
Facilities
Manufacturing facilities in North America and Asia. Class 1,000, 10,000, and 100,000 clean rooms.
IDEX Health & Science LLC
619 Oak Street
Oak Harbor, WA 98277
TELEPHONE
(866) 339-4653
FAX
(360) 682-4151
WEB SITE
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.